Integra Lifesciences Holdings Corp (IART)
28.89
+0.14
(+0.49%)
USD |
NASDAQ |
May 03, 16:00
28.86
-0.03
(-0.10%)
After-Hours: 20:00
Integra Lifesciences Holdings SG&A Expense (Quarterly): 163.13M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 163.13M |
September 30, 2023 | 161.95M |
June 30, 2023 | 164.91M |
March 31, 2023 | 166.66M |
December 31, 2022 | 151.92M |
September 30, 2022 | 143.82M |
June 30, 2022 | 160.65M |
March 31, 2022 | 159.93M |
December 31, 2021 | 162.25M |
September 30, 2021 | 156.01M |
June 30, 2021 | 162.55M |
March 31, 2021 | 156.63M |
December 31, 2020 | 162.39M |
September 30, 2020 | 150.08M |
June 30, 2020 | 116.11M |
March 31, 2020 | 165.95M |
December 31, 2019 | 174.25M |
September 30, 2019 | 173.10M |
June 30, 2019 | 165.38M |
March 31, 2019 | 174.87M |
December 31, 2018 | 177.23M |
September 30, 2018 | 173.36M |
June 30, 2018 | 176.60M |
March 31, 2018 | 163.57M |
December 31, 2017 | 190.64M |
Date | Value |
---|---|
September 30, 2017 | 145.94M |
June 30, 2017 | 145.02M |
March 31, 2017 | 142.50M |
December 31, 2016 | 112.12M |
September 30, 2016 | 112.32M |
June 30, 2016 | 119.22M |
March 31, 2016 | 111.98M |
December 31, 2015 | 109.75M |
September 30, 2015 | 113.42M |
June 30, 2015 | 99.32M |
March 31, 2015 | 93.26M |
December 31, 2014 | 92.49M |
September 30, 2014 | 93.79M |
June 30, 2014 | 115.25M |
March 31, 2014 | 108.34M |
December 31, 2013 | 26.15M |
September 30, 2013 | 99.79M |
June 30, 2013 | 103.28M |
March 31, 2013 | 102.96M |
December 31, 2012 | 96.53M |
September 30, 2012 | 93.08M |
June 30, 2012 | 96.10M |
March 31, 2012 | 87.41M |
December 31, 2011 | 94.81M |
September 30, 2011 | 87.51M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
116.11M
Minimum
Jun 2020
174.25M
Maximum
Dec 2019
158.82M
Average
162.25M
Median
Dec 2021
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.84B |
OraSure Technologies Inc | 20.91M |
Insulet Corp | 212.80M |
PROCEPT BioRobotics Corp | 39.60M |
Perspective Therapeutics Inc | 1.694M |